Binetti, Giuliano
for the FRONTIERS group
22 papers on CoChatORCID 0000-0003-2759-5844
Most cited papers
- Verified
New insights into the genetic etiology of Alzheimer’s disease and related dementias
Bellenguez, C., Küçükali, F., Jansen, I. E., Kleineidam, L., Moreno-Grau, S., Amin, N., Naj, A. C., Campos-Martin, R., Grenier-Boley, B., Andrade, V., et al. (2022) · Nature Genetics
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 2,498
- Verified
Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with subtype and Stage inference
Young, A. L., Marinescu, R. V., Oxtoby, N. P., Bocchetta, M., Yong, K., Firth, N. C., Cash, D. M., Thomas, D. L., Dick, K. M., Cardoso, J., et al. (2018) · Nature Communications
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 596
- Verified
Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis
Rohrer, J. D., Nicholas, J. M., Cash, D. M., van Swieten, J., Dopper, E., Jiskoot, L., van Minkelen, R., Rombouts, S. A., Cardoso, M. J., Clegg, S., et al. (2015) · The Lancet Neurology
Dementia and Cognitive Impairment ResearchAmyotrophic Lateral Sclerosis Research
Cited by 538
- Verified
Frontotemporal dementia and its subtypes: a genome-wide association study
Ferrari, R., Hernandez, D. G., Nalls, M. A., Rohrer, J. D., Ramasamy, A., Kwok, J. B. J., Dobson-Stone, C., Brooks, W. S., Schofield, P. R., Halliday, G. M., et al. (2014) · The Lancet Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 383
- Verified
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores
de Rojas, I., Moreno-Grau, S., Tesi, N., Grenier-Boley, B., Andrade, V., Jansen, I. E., Pedersen, N. L., Stringa, N., Zettergren, A., Hernández, I., et al. (2021) · Nature Communications
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 324
- Verified
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study
Moore, K. M., Nicholas, J., Grossman, M., McMillan, C. T., Irwin, D. J., Massimo, L., Van Deerlin, V. M., Warren, J. D., Fox, N. C., Rossor, M. N., et al. (2020) · The Lancet Neurology
Amyotrophic Lateral Sclerosis ResearchDementia and Cognitive Impairment Research
Cited by 313
- Verified
Conversion from mild cognitive impairment to Alzheimer’s disease is predicted by sources and coherence of brain electroencephalography rhythms
Rossini, P. M., Del Percio, C., Pasqualetti, P., Cassetta, E., Binetti, G., Dal Forno, G., Ferreri, F., Frisoni, G., Chiovenda, P., Miniussi, C., et al. (2006) · Neuroscience
Dementia and Cognitive Impairment ResearchEEG and Brain-Computer Interfaces
Cited by 281
- Verified
TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers
Finch, N., Carrasquillo, M. M., Baker, M., Rutherford, N. J., Coppola, G., DeJesus-Hernandez, M., Crook, R., Hunter, T., Ghidoni, R., Benussi, L., et al. (2011) · Neurology
Amyotrophic Lateral Sclerosis ResearchAlzheimer's disease research and treatments
Cited by 243
- Verified
Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study
van der Ende, E. L., Meeter, L. H., Poos, J. M., Panman, J. L., Jiskoot, L. C., Dopper, E. G. P., Papma, J. M., de Jong, F. J., Verberk, I. M. W., Teunissen, C., et al. (2019) · The Lancet Neurology
Amyotrophic Lateral Sclerosis ResearchDementia and Cognitive Impairment Research
Cited by 181
- Verified
Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia
Swarup, V., Hinz, F. I., Rexach, J. E., Noguchi, K.-I., Toyoshiba, H., Oda, A., Hirai, K., Sarkar, A., Seyfried, N. T., Cheng, C., et al. (2019) · Nature Medicine
Alzheimer's disease research and treatmentsBioinformatics and Genomic Networks
Cited by 136
- Verified
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study
Pottier, C., Zhou, X., Perkerson, R. B., Baker, M., Jenkins, G. D., Serie, D. J., Ghidoni, R., Benussi, L., Binetti, G., López de Munain, A., et al. (2018) · The Lancet Neurology
Amyotrophic Lateral Sclerosis ResearchAlzheimer's disease research and treatments
Cited by 131
- Verified
Serum Glial Fibrillary Acidic Protein (GFAP) Is a Marker of Disease Severity in Frontotemporal Lobar Degeneration
Benussi, A., Ashton, N. J., Karikari, T. K., Gazzina, S., Premi, E., Benussi, L., Ghidoni, R., Rodriguez, J. L., Emeršič, A., Binetti, G., et al. (2020) · Journal of Alzheimer’s Disease
Dementia and Cognitive Impairment ResearchAmyotrophic Lateral Sclerosis Research
Cited by 113
- Verified · note
Cognitive telerehabilitation in mild cognitive impairment, Alzheimer’s disease and frontotemporal dementia: A systematic review
Cotelli, M., Manenti, R., Brambilla, M., Gobbi, E., Ferrari, C., Binetti, G., & Cappa, S. F. (2019) · Journal of Telemedicine and Telecare
Dementia and Cognitive Impairment ResearchTelemedicine and Telehealth Implementation
Cited by 112
- Verified
A comprehensive study of the genetic impact of rare variants in SORL1 in European early-onset Alzheimer’s disease
Verheijen, J., Van den Bossche, T., van der Zee, J., Engelborghs, S., Sanchez-Valle, R., Lladó, A., Graff, C., Thonberg, H., Pastor, P., Ortega-Cubero, S., et al. (2016) · Acta Neuropathologica
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 112
- Verified
Incidence of Syndromes Associated With Frontotemporal Lobar Degeneration in 9 European Countries
Logroscino, G., Piccininni, M., Graff, C., Hardiman, O., Ludolph, A. C., Moreno, F., Otto, M., Remes, A. M., Rowe, J. B., Seelaar, H., et al. (2023) · JAMA Neurology
Dementia and Cognitive Impairment ResearchAmyotrophic Lateral Sclerosis Research
Cited by 91
- Verified
Effect of energy shortage and oxidative stress on amyloid precursor protein metabolism in COS cells
Gasparini, L., Racchi, M., Benussi, L., Curti, D., Binetti, G., Bianchetti, A., Trabucchi, M., & Govoni, S. (1997) · Neuroscience Letters
Alzheimer's disease research and treatmentsMitochondrial Function and Pathology
Cited by 89
- Verified
Deleterious ABCA7 mutations and transcript rescue mechanisms in early onset Alzheimer’s disease
On behalf of the European Early-Onset Dementia (EU EOD) consortium, De Roeck, A., Van den Bossche, T., van der Zee, J., Verheijen, J., De Coster, W., Van Dongen, J., Dillen, L., Baradaran-Heravi, Y., Heeman, B., et al. (2017) · Acta Neuropathologica
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 74
- Verified
Rac1 activation links tau hyperphosphorylation and Aβ dysmetabolism in Alzheimer’s disease
Borin, M., Saraceno, C., Catania, M., Lorenzetto, E., Pontelli, V., Paterlini, A., Fostinelli, S., Avesani, A., Di Fede, G., Zanusso, G., et al. (2018) · Acta Neuropathologica Communications
Alzheimer's disease research and treatmentsProtein Kinase Regulation and GTPase Signaling
Cited by 68
- Verified
Novel CSF biomarkers in genetic frontotemporal dementia identified by proteomics
van der Ende, E. L., Meeter, L. H., Stingl, C., van Rooij, J. G. J., Stoop, M. P., Nijholt, D. A. T., Sanchez‐Valle, R., Graff, C., Öijerstedt, L., Grossman, M., et al. (2019) · Annals of Clinical and Translational Neurology
Amyotrophic Lateral Sclerosis ResearchAlzheimer's disease research and treatments
Cited by 65
- Verified
Poly(GP), neurofilament and grey matter deficits in C9orf72 expansion carriers
Meeter, L. H. H., Gendron, T. F., Sias, A. C., Jiskoot, L. C., Russo, S. P., Donker Kaat, L., Papma, J. M., Panman, J. L., van der Ende, E. L., Dopper, E. G., et al. (2018) · Annals of Clinical and Translational Neurology
Amyotrophic Lateral Sclerosis ResearchGenetic Neurodegenerative Diseases
Cited by 61
- Verified
Possible association of mitochondrial transcription factor A (TFAM) genotype with sporadic Alzheimer disease
Günther, C., Hadeln, K. V., Müller-Thomsen, T., Alberici, A., Binetti, G., Hock, C., Nitsch, R. M., Stoppe, G., Reiss, J., Gal, A., et al. (2004) · Neuroscience Letters
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 53
- Verified
Quantitative genetics validates previous genetic variants and identifies novel genetic players influencing Alzheimer’s disease cerebrospinal fluid biomarkers
Ramos de Matos, M., Ferreira, C., Herukka, S.-K., Soininen, H., Janeiro, A., Santana, I., Baldeiras, I., Almeida, M. R., Lleó, A., Dols-Icardo, O., et al. (2018) · Journal of Alzheimer's Disease
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 18
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free